These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15374946)

  • 1. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
    Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
    Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxycholic acid promotes the growth of colonic aberrant crypt foci.
    Flynn C; Montrose DC; Swank DL; Nakanishi M; Ilsley JN; Rosenberg DW
    Mol Carcinog; 2007 Jan; 46(1):60-70. PubMed ID: 17091474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
    Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW
    Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azoxymethane induces KI-ras activation in the tumor resistant AKR/J mouse colon.
    Bolt AB; Papanikolaou A; Delker DA; Wang QS; Rosenberg DW
    Mol Carcinog; 2000 Mar; 27(3):210-8. PubMed ID: 10708483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.
    Bird RP
    Cancer Lett; 1995 Jun; 93(1):55-71. PubMed ID: 7600544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
    Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
    Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aberrant crypt foci by chemopreventive agents.
    Olivo S; Wargovich MJ
    In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
    Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
    Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
    Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
    Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
    Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary iron promotes azoxymethane-induced colon tumors in mice.
    Ilsley JN; Belinsky GS; Guda K; Zhang Q; Huang X; Blumberg JB; Milbury PE; Roberts LJ; Stevens RG; Rosenberg DW
    Nutr Cancer; 2004; 49(2):162-9. PubMed ID: 15489209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors.
    Nambiar PR; Girnun G; Lillo NA; Guda K; Whiteley HE; Rosenberg DW
    Int J Oncol; 2003 Jan; 22(1):145-50. PubMed ID: 12469197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.